Identification of genetic disparity between primary and metastatic melanoma in human patients

Genes Chromosomes and Cancer

Volumn 50, Issue 9, 2011, Pages 680-688

  Swoboda, Alexander ^a   Rasin Streden, Doris ^a   Schanab, Oliver ^a   Okamoto, Ichiro ^a   Pehamberger, Hubert ^a   Petzelbauer, Peter ^a   Mikula, Mario ^a,b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADULT; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 4; DNA COPY NUMBER VARIATIONS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; X CHROMOSOME;

EID: 79960160914     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20890     Document Type: Article

References (35)

1. Aubert C, Rouge F, Galindo JR. 1980. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Natl Cancer Inst 64: 1029-1040.
2. Boni R, Matt D, Voetmeyer A, Burg G, Zhuang Z. 1998. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Investig Dermatol 110: 215-217.
3. Buick RN, Fry SE, Salmon SE. 1980. Application of in vitro soft agar techniques for growth of tumor cells to the study of colon cancer. Cancer 45: 1238-1242.
4. Dong JT, Chen C, Stultz BG, Isaacs JT, Frierson HF, Jr. 2000. Deletion at 13q21 is associated with aggressive prostate cancers. Cancer Res 60: 3880-3883.
5. Edgar R, Domrachev M, Lash AE. 2002. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
6. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C, Kamb A. 1995. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 146: 1199-1206.
7. Hirakawa S. 2009. From tumor lymphangiogenesis to lymphvascular niche. Cancer Sci 100: 983-989.
8. Houghton AN, Real FX, Davis LJ, Cordon-Cardo C, Old LJ. 1987. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med 165: 812-829.
9. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA. 2008. Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68.
10. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, III, Johnson BE, Skolnick MH. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
11. Klein CA. 2009. Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: 302-312.
12. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G. 2002. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360: 683-689.
13. Larramendy ML, Tarkkanen M, Blomqvist C, Virolainen M, Wiklund T, Asko-Seljavaara S, Elomaa I, Knuutila S. 1997. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151: 1153-1161.
14. Lin J, Takata M, Murata H, Goto Y, Kido K, Ferrone S, Saida T. 2009. Polyclonality of BRAF mutations in acquired melanocytic nevi. J Natl Cancer Inst 101: 1423-1427.
15. Liu C, Cummins TR, Tyrrell L, Black JA, Waxman SG, Dib-Hajj SD. 2005. CAP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Na(v)1.8. Mol Cell Neurosci 28: 636-649.
16. Loewe R, Kittler H, Fischer G, Fae I, Wolff K, Petzelbauer P. 2004. BRAF kinase gene V599E mutation in growing melanocytic lesions. J Investig Dermatol 123: 733-736.
17. Mansfield AS, Markovic SN. 2009. Novel therapeutics for the treatment of metastatic melanoma. Future Oncol 5: 543-557.
18. Mikula M, Gotzmann J, Fischer AN, Wolschek MF, Thallinger C, Schulte-Hermann R, Beug H, Mikulits W. 2003. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22: 6725-6738.
19. Mikula M, Proell V, Fischer AN, Mikulits W. 2006. Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209: 560-567.
20. Morita R, Fujimoto A, Hatta N, Takehara K, Takata M. 1998. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Investig Dermatol 111: 919-924.
21. Ooshio T, Irie K, Morimoto K, Fukuhara A, Imai T, Takai Y. 2004. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells. J Biol Chem 279: 31365-31373.
22. Palmieri G, Cossu A, Ascierto PA, Botti G, Strazzullo M, Lissia A, Colombino M, Casula M, Floris C, Tanda F, Pirastu M, Castello G. 2000. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group. Br J Cancer 83: 1707-1714.
23. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116: 511-526.
24. Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, Lanier LL. 2008. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol 180: 6508-6517.
25. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
26. Smalley KS, Haass NK, Brafford PA, Lioni M, Flaherty KT, Herlyn M. 2006. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther 5: 1136-1144.
27. Stoecklein NH, Klein CA. 2010. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer 126: 589-598.
28. Stoecklein NH, Hosch SB, Bezler M, Stern F, Hartmann CH, Vay C, Siegmund A, Scheunemann P, Schurr P, Knoefel WT, Verde PE, Reichelt U, Erbersdobler A, Grau R, Ullrich A, Izbicki JR, Klein CA. 2008. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13: 441-453.
29. Tanaka-Okamoto M, Hori K, Ishizaki H, Hosoi A, Itoh Y, Wei M, Wanibuchi H, Mizoguchi A, Nakamura H, Miyoshi J. 2009. Increased susceptibility to spontaneous lung cancer in mice lacking LIM-domain only 7. Cancer Sci 100: 608-616.
30. Taniguchi CM, Winnay J, Kondo T, Bronson RT, Guimaraes AR, Aleman JO, Luo J, Stephanopoulos G, Weissleder R, Cantley LC, Kahn CR. 2010. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res 70: 5305-5315.
31. Touloukian CE, Leitner WW, Schnur RE, Robbins PF, Li Y, Southwood S, Sette A, Rosenberg SA, Restifo NP. 2003. Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1. J Immunol 170: 1579-1585.
32. Widera D, Zander C, Heidbreder M, Kasperek Y, Noll T, Seitz O, Saldamli B, Sudhoff H, Sader R, Kaltschmidt C, Kaltschmidt B. 2009. Adult palatum as a novel source of neural crest-related stem cells. Stem Cells 27: 1899-1910.
33. Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AF. 1998. Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res 4: 2931-2938.
34. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1, and TBLR1. EMBO J 22: 1336-1346.
35. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. 1998. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: Stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18: 1379-1387.